Drugs / GW427353
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00394186 | Aug 2006 → ? | irritable bowel syndrome | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW427353 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00394186 ↗ |
| Action | Activate | “a beta-3 adrenergic agonist” NCT00394186 ↗ |